Biotech

All Articles

Sanofi pays for $110M upfront for late-stage radioligand therapy

.Sanofi has made an overdue entry to the radioligand party, paying for one hundred million europeans...

F 2G increases $100M for second effort to get new antifungal to market

.After F2G's very first attempt to obtain a brand-new course of antifungal to market was thwarted du...

Moderna targets $1.1 B in R&ampD spending slices, falls 5 plans amid earnings tensions

.Moderna has sworn to reduce R&ampD costs through $1.1 billion by 2027. The selection to shrink the ...

Sanofi's $80M bet on Fulcrum dystrophy medication ends in period 3 fail

.Just 4 months after Sanofi bet $80 million in upfront money on Pivot Rehabs' losmapimod, the system...

Oncternal stock sinks 60% amidst unemployments, trial discontinuations

.Cancer cells company Oncternal Rehabs is actually folding all its professional trials as well as gi...

Roche is holding out chances that its injectable weight problems prospect can at some point demonstrate 25% weight management in late-stage trial

.Roche is keeping out chances that its injectable excessive weight prospect might ultimately show 25...

Novo Nordisk hails 'remarkable' weight reduction lead for dual-acting oral drug in very early trial

.Novo Nordisk has raised the top on a phase 1 test of its own dental amylin and also GLP-1 receptor ...

AbbVie files a claim against BeiGene over blood stream cancer cells drug secret method

.Just a handful of short weeks after winning an FDA Fast Track tag for its investigational BTK degra...

Lilly provides one-two strike along with 2nd tranche of favorable data on weekly insulin prospect

.Quickly after a beneficial information decrease for Eli Lilly's efsitora alfa, the Indianapolis-bas...

BridgeBio reduces genetics therapy budget as professional data let down

.BridgeBio Pharma is actually slashing its gene treatment budget and drawing back coming from the mo...